KPV

KPV is a Anti-Inflammatory Tripeptide supplied for laboratory research. Alpha-MSH-derived tripeptide investigated in vitro for gut barrier signaling, inflammatory cytokine pathway modeling, and mucosal tissue mechanism research.

KPV (Lys-Pro-Val) is the C-terminal tripeptide fragment of the hormone alpha-MSH. It is studied in vitro for anti-inflammatory and gut-barrier signaling.

Yes. KPV is one of the four components of the Klow blend, where it is combined with BPC-157, TB-500, and GHK-Cu to contribute an anti-inflammatory tripeptide.

KPV is supplied as a lyophilized (freeze-dried) powder — a dehydrated form that keeps the peptide stable during shipping and storage. In the laboratory it is reconstituted (returned to liquid form) using a solvent such as bacteriostatic water, added slowly against the side of the vial, which is then swirled gently — never shaken — until the powder fully dissolves. All handling is for in vitro research use only.

Store the lyophilized KPV powder at -20°C, protected from light and moisture, where it remains stable long-term. Once reconstituted, keep it refrigerated (2-8°C) and use it within the timeframe appropriate for your research protocol.

Every batch of KPV is produced to a purity of 99% or higher. Purity and molecular identity are verified using standard analytical methods — high-performance liquid chromatography (HPLC) to measure purity, and mass spectrometry (MS) to confirm the peptide's molecular weight.